NHI demonstrated solid operational performance with 12% revenue growth and strong operating leverage, while substantially increasing capital investments.
The company appears to be in an active expansion phase, with capital expenditures nearly doubling year-over-year, suggesting significant property acquisitions or development activities typical for a healthcare REIT. The strong operating cash flow growth of 14% provides adequate coverage for the increased investment spending, indicating disciplined capital allocation.
NHI delivered balanced growth across key metrics, with revenue expanding 12% to $376M and operating income growing 46% to $150M, demonstrating strong operational leverage. Capital expenditures increased substantially to $294M, reflecting significant investment activity, while operating cash flow grew a healthy 14% to $237M. The slight decline in cash balances to $20M appears manageable given the strong cash generation, with stockholders' equity growing 11% to $1.5B, indicating a solid financial foundation supporting the expansion strategy.
Capital expenditure jumped 86.2% — major investment cycle underway; assess returns on deployment.
Operating leverage kicking in — revenue growth outpacing cost growth, a hallmark of scaling businesses.
Cash decreased 19.2% — monitor burn rate and upcoming capital needs.
Operating cash flow grew 13.9% — strong conversion of earnings to cash, healthy business fundamentals.
Receivables grew 12.8% — monitor days sales outstanding for collection efficiency.
Revenue growing 12.1% — solid top-line momentum, watch margins for quality of growth.
Equity base grew 11.3% — retained earnings accumulation or equity issuance strengthening the balance sheet.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →